dr. flinn on the innovate trial in waldenstrom macroglobulinemia
Published 5 years ago • 141 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
0:27
copy of dr. flinn on the relevance trial in follicular lymphoma
-
1:30
dr. flinn on the relevance trial in follicular lymphoma
-
55:45
waldenstrom macroglobulinemia
-
2:02
dr. treon on breakthroughs in waldenström’s macroglobulinemia
-
1:06
dr. ansell describes waldenström macroglobulinemia
-
1:16
dr. flinn on the utility of tafasitamab in relapsed/refractory dlbcl
-
6:39
diagnosing waldenström macroglobulinemia
-
0:54
dr. flinn discusses the dynamo trial
-
13:34
debate: what is the treatment choice for waldenstrom macroglobulinemia? - bendamustine
-
4:18
waldenström macroglobulinemia: non-btk novel strategies
-
1:09
dr. flinn on opportunities for second-line tafasitamab in dlbcl
-
0:51
dr. ansell on waldenström macroglobulinemia symptoms
-
1:34
innovate study update: long-term pfs in wm
-
1:30
bendamustine-rituximab vs ibrutinib as frontline therapy in waldenström's macroglobulinemia
-
3:03
long-term follow-up of ibrutinib in waldenström's macroglobulinemia
-
1:01
dr. stephen ansell on treating patients with waldenström macroglobulinemia
-
1:58
therapeutic agents being explored in waldenström’s macroglobulinemia trials
-
5:00
defining waldenström macroglobulinemia
-
1:12
dr. dimopoulos on the utility of zanubrutinib in waldenström macroglobulinemia